90 likes | 199 Views
Hippisley-Cox J, Coupland C. Heart 2010;96:939-47. Baseline characteristics of new users of statins and non-users of statins aged 30-84 years in the QResearch derivation and THIN validation cohorts. Hippisley-Cox J, Coupland C. Heart 2010;96:939-47.
E N D
Baseline characteristics of new users of statins and non-users of statins aged 30-84 years in the QResearch derivation and THIN validation cohorts Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
Adjusted HRs (95% CI) for moderate to severe myopathyModels also adjusted for age and body mass index Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
Validation statistics for each model in the THIN and QResearch validation cohorts Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
Adjusted HRs (95% CI) for acute renal failure Models also adjusted for age and body mass index Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
Adjusted HR (95% CI) for moderate/serious liver dysfunction Models also adjusted for age and body mass index Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
Adjusted HR (95% CI) for cataract Models also adjusted forage and body mass index Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
Predicted to observed risk of each outcome using the QResearch database Hippisley-Cox J, Coupland C. Heart 2010;96:939-47
Numbers needed to harm (NNH) or numbers needed to treat (NNT) and numbers of extra or prevented cases, for each outcome over 5 years in patients aged 35-74 free of cardiovascular disease at baseline with QRISK2 score of 20%+ Hippisley-Cox J, Coupland C. Heart 2010;96:939-47